AI Article Synopsis

  • A pilot study assessed 46 patients with advanced heart failure to see if they could benefit from home parenteral diuretic treatment and evaluated various assessment tools.
  • Out of the patients, 30% received intravenous treatment, 24% received subcutaneous treatment, while 20% needed medication adjustments; however, 17% could not be treated due to staffing limitations.
  • The treatment effectively minimized hospital admissions and alleviated heart failure symptoms, with positive feedback from both patients and caregivers regarding the care provided.

Article Abstract

Referrals of 46 patients with decompensated end-stage heart failure were reviewed by a community heart-failure specialist nurse as part of a pilot study to determine patient numbers suitable for parenteral diuretic treatment at home, and the appropriateness of the Mini Nutritional Assessment (MNA), Edmonton Symptom Assessment System (ESAS) and Carer's Stress Scales. Triage of patients resulted in the following care pathways: 14 (30%) received intravenous therapy, 11 (24%) received subcutaneous therapy, 9 (20%) required adjustment of medication, 8 (17%) could not be treated because of limited staffing resource, 4 (9%) met study exemption criteria. There were no adverse events following furosemide infusion. The majority of intravenous and subcutaneous treatments took 1-7 days (total 187 days). Parenteral diuretic therapy prevented admissions and reduced the severity heart failure symptoms in particular oedema. Patients and carers appreciated the service, which had a positive effect on carers stress. Of the nursing tools, the ESAS and the Carer's Stress Scales proved useful in the management of patients.

Download full-text PDF

Source
http://dx.doi.org/10.12968/bjcn.2013.18.11.528DOI Listing

Publication Analysis

Top Keywords

parenteral diuretic
12
heart failure
12
diuretic treatment
8
esas carer's
8
carer's stress
8
stress scales
8
assessing parenteral
4
treatment decompensated
4
decompensated heart
4
failure community
4

Similar Publications

Background: The ductus arteriosus is a blood vessel connecting the main pulmonary artery and the proximal descending aorta. After birth, the ductus arteriosus usually closes completely. However, sometimes it remains patent in the neonate, which is called patent ductus arteriosus (PDA).

View Article and Find Full Text PDF
Article Synopsis
  • Inpatient hospices (IHs) showed potential to reduce distress and financial burden for terminal lung cancer patients, but findings on cost savings and medication use were inconsistent.
  • A study analyzed data from 31,139 Korean patients who died between 2017 and 2020, focusing on hospitalization costs and medication use depending on the timing of their first hospitalization before death.
  • Results indicated that IHs had lower costs during the final 30 days of life but no difference in total costs for the year before death, and they prescribed significantly more opioid analgesics and other symptom-oriented medications compared to non-IHs.
View Article and Find Full Text PDF

Isolated Pulmonic Valve Endocarditis: A Rare Clinical Entity.

Clin Med Insights Case Rep

August 2024

Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Article Synopsis
  • Isolated pulmonic valve endocarditis is a rare heart valve infection, making up only 1-2% of all infective endocarditis cases, and was diagnosed using modified Duke's criteria in this case.
  • A 52-year-old male presented with symptoms like body swelling, prolonged fever, cough, and discolored urine, alongside signs of heart failure and other health issues detected during examination and lab tests.
  • Diagnosis was confirmed by echocardiography showing vegetations on the pulmonic valve, supported by the presence of one major and three minor criteria from the modified Duke's criteria, leading to significant improvement after two weeks of intravenous treatment.
View Article and Find Full Text PDF

Role of spot urinary sodium in outpatients with heart failure.

Rev Esp Cardiol (Engl Ed)

July 2024

Servicio de Cardiología, Hospital Clínico Universitario de Valencia, Valencia, Spain; Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain; Facultad de Medicina, Universitat de València, Valencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain. Electronic address:

Introduction And Objectives: Spot determination of urinary sodium (UNa+) has emerged as a useful tool for monitoring diuretic response in patients with acute heart failure (AHF). However, the evidence in outpatients is scarce. We aimed to examine the relationship between spot UNa+ levels and the risk of mortality and worsening heart failure (WHF) events in individuals with chronic HF.

View Article and Find Full Text PDF

Background: With a wide therapeutic index, efficacy, ease of use, and other neuroprotective and respiratory benefits, caffeine citrate(CC) is currently the drug of choice for preterm neonates (PTNs). Caffeine-induced excessive energy expenditure, diuresis, natriuresis, and other CC-associated potential side-effects (CC-APSEs) result in lower daily-weight gain (WG) in premature neonates. This study aimed to evaluate the risk factors for daily-WG in neonates exposed to different dose regimens of caffeine in ICU.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!